Hub : Traits :

High blood pressure

1021 significantly associated models · 334 unique genes.

Significant Loci

# chr p0 p1 # assoc genes # joint genes best TWAS P best SNP P cond SNP P % var exp joint genes
1 1 752566 2061969 1 1 3.4e-07 6.6e-06 5.7e-03 62 RP4-758J18.10
2 1 7715776 9571422 2 1 2.2e-08 6.7e-08 2.9e-01 96 RP5-1115A15.1
3 1 10435170 12769239 9 9 9.8e-21 9.5e-31 0.0e+00 -2040 AGTRAP CLCN6 DRAXIN MFN2 NPPA-AS1 RP4-635E18.7
4 1 26428864 28406173 3 2 1.7e-08 3.6e-07 7.7e-01 100 CD164L2 PIGV
5 1 42542658 43960530 1 1 3.2e-07 9.5e-07 1.5e-01 91 C1orf50
6 1 88621347 90053563 1 1 1.5e-10 2.5e-10 1.2e-01 94 GTF2B
7 1 112312154 113941737 4 2 1.6e-12 1.8e-20 3.9e-14 33 WNT2B
8 1 115136771 116932921 2 2 1.2e-07 1.5e-11 3.4e-09 23 NGF VANGL1
9 1 230142626 231548480 1 1 2.0e-10 3.7e-10 3.3e-01 98 AGT
10 2 24021231 26068509 3 1 7.9e-11 5.6e-10 3.1e-02 88 NCOA1
11 2 26223547 27689899 2 2 1.7e-08 2.0e-33 1.3e-24 28 KCNK3 SLC35F6
12 2 36778887 38298877 2 1 6.8e-10 3.6e-09 1.0e+00 100 PRKD3
13 2 158621356 160236990 1 1 3.2e-07 2.3e-08 5.8e-04 62 PKP4
14 2 181139278 184084221 2 2 7.7e-08 3.7e-08 1.1e-11 -52 PDE1A UBE2E3
15 2 218622292 220128895 1 1 3.3e-07 1.0e-04 1.5e-04 5 USP37
16 3 10617048 12293966 1 1 3.9e-08 1.7e-10 9.1e-04 73 ATG7
17 3 19382787 20920840 2 1 3.5e-08 1.3e-08 7.1e-02 90 KAT2B
18 3 26563909 28211713 2 1 5.1e-21 4.2e-18 6.1e-05 79 SLC4A7
19 3 47204518 49365269 8 1 3.7e-11 2.5e-11 1.0e+00 100 FCF1P2
20 3 55955214 57412804 1 1 2.8e-07 3.7e-06 6.2e-02 84 C3orf63
21 3 127097277 128821807 2 1 1.1e-07 5.8e-09 2.4e-03 73 RUVBL1
22 3 133088362 134666475 1 1 2.5e-07 8.1e-10 5.9e-04 69 RYK
23 3 137189600 138819532 2 1 1.1e-08 9.0e-09 2.3e-01 96 DBR1
24 3 157125828 158980014 2 1 7.3e-09 1.3e-07 2.9e-01 96 RP11-538P18.2
25 3 183204923 184607480 1 1 1.0e-07 3.4e-07 3.9e-01 97 ABCF3
26 4 17104059 18507692 1 1 1.8e-09 4.3e-09 1.8e-02 84 DCAF16
27 4 25880334 27452482 1 1 1.6e-11 1.2e-14 2.6e-06 63 TBC1D19
28 4 37915462 39361551 1 1 2.9e-09 8.8e-09 1.3e-04 56 FLJ13197
29 4 80407869 82578407 3 2 4.3e-20 1.1e-65 1.8e-42 36 C4orf22 PRDM8
30 4 102852939 104627833 6 1 2.3e-11 3.7e-10 8.2e-01 100 CISD2
31 4 110590479 112179424 1 1 2.9e-07 6.4e-13 5.9e-09 34 ENPEP
32 4 155890241 157354250 2 1 2.2e-08 6.7e-12 8.1e-11 10 RP11-588K22.2
33 5 32015725 33484084 1 1 1.1e-07 7.3e-31 5.4e-25 20 NPR3
34 5 60903201 62529686 1 2 5.3e-08 9.8e-08 6.3e-01 99 KIF2A
35 5 113762810 115330276 2 1 4.0e-10 1.2e-11 5.2e-04 74 CCDC112
36 5 130830617 132425049 7 1 1.4e-08 4.4e-08 2.1e-01 95 PDLIM4
37 6 14551209 16209635 1 1 2.5e-07 6.9e-07 1.1e-02 74 JARID2
38 6 42586058 44034691 1 1 2.4e-10 2.6e-13 2.3e-04 75 ZNF318
39 6 78880271 80486611 2 1 6.2e-08 3.1e-07 4.7e-01 98 PHIP
40 6 96275538 97699026 1 1 1.5e-07 7.3e-08 1.4e-01 93 UFL1
41 6 117187910 118613435 1 1 1.5e-07 4.4e-10 4.3e-10 0 GOPC
42 6 125970401 128536730 3 3 2.2e-12 1.2e-30 1.4e-13 59 C6orf174 CENPW PRELID1P1
43 7 1854263 3264728 1 1 2.6e-10 4.5e-10 1.0e+00 100 LFNG
44 7 6502367 7988091 1 1 1.6e-13 4.9e-10 1.0e-01 93 C1GALT1
45 7 73425238 75714883 6 2 6.9e-09 1.6e-08 3.8e-01 98 PMS2P5 STAG3L1
46 7 76506844 77966572 1 1 1.1e-07 8.0e-07 6.8e-02 86 PTPN12
47 7 99122437 100516003 1 1 7.2e-08 4.3e-07 5.2e-01 98 PVRIG
48 7 129342404 130779678 1 1 1.5e-08 1.2e-12 6.7e-12 7 CEP41
49 7 132241297 134834499 2 3 3.3e-08 8.6e-08 5.3e-01 99 AKR1B1 EXOC4
50 8 8092025 13120332 27 2 8.2e-16 8.2e-14 6.2e-04 79 MSRA NEIL2
51 8 29996824 31433801 1 1 6.3e-08 2.0e-08 1.3e-01 93 TEX15
52 8 90238179 91633434 1 1 2.1e-07 4.7e-08 4.2e-02 86 OSGIN2
53 8 95213858 96825195 1 1 1.3e-07 1.1e-06 3.6e-01 96 NDUFAF6
54 8 102002608 103832256 2 1 3.3e-09 9.5e-10 5.4e-04 68 KB-1107E3.1
55 9 35208145 36597142 1 1 1.2e-08 1.1e-08 4.1e-03 75 HRCT1
56 10 18221643 19601824 1 1 1.7e-08 1.2e-16 3.6e-14 16 NSUN6
57 10 63856856 65606229 3 3 9.9e-13 6.7e-12 2.5e-01 97 NRBF2 RP11-436D10.3
58 10 87729214 88960852 1 1 2.5e-07 4.1e-07 7.0e-02 87 LDB3
59 10 95379543 96988739 2 2 1.9e-10 8.0e-13 5.8e-03 85 NOC3L TBC1D12
60 10 103313599 105850787 9 1 1.3e-14 3.0e-16 6.6e-03 89 NT5C2
61 10 115244596 116689519 1 1 1.5e-07 1.7e-21 6.1e-17 23 TDRD1
62 11 1213806 2705175 3 2 7.6e-20 3.5e-23 4.1e-04 87 TNNT3
63 11 9003306 10471931 1 1 1.0e-08 1.2e-11 1.2e-04 68 SWAP70
64 11 16532857 18106069 2 1 1.8e-07 2.2e-07 2.2e-01 94 KCNJ11
65 11 42881882 44596817 2 1 6.9e-08 2.4e-09 7.2e-03 80 RP11-613D13.5
66 11 46010847 48783497 19 1 4.2e-25 1.8e-20 5.7e-07 71 ACP2
67 11 56370106 57784307 1 1 2.7e-07 1.2e-08 1.1e-05 41 TNKS1BP1
68 11 64721908 66333072 2 1 1.9e-09 5.7e-12 1.4e-06 51 SIPA1
69 11 99859184 101559718 2 1 2.7e-35 1.4e-33 1.8e-01 99 TMEM133
70 11 106485489 108027561 2 1 1.7e-10 1.1e-10 1.2e-03 75 CWF19L2
71 11 110721187 112491227 5 1 3.5e-10 3.1e-10 1.0e+00 100 SIK2
72 11 125457894 126865035 1 1 3.5e-07 3.4e-05 9.4e-01 100 TIRAP
73 12 26480758 27916206 1 1 1.7e-07 6.1e-07 1.0e+00 100 MED21
74 12 47407397 49444545 4 2 4.2e-08 1.3e-09 1.4e-04 61 RP1-197B17.3 SENP1
75 12 49673158 51256065 4 2 9.0e-11 4.5e-13 5.0e-10 26 AQP5 CERS5
76 12 66965631 68410906 1 1 3.4e-08 3.4e-08 1.0e+00 100 CAND1
77 12 69057879 70476863 1 1 1.2e-08 6.8e-08 1.0e+00 100 YEATS4
78 12 89116708 90799212 2 1 5.3e-16 3.8e-25 2.5e-15 42 ATP2B1
79 12 109591369 111015121 1 1 1.0e-08 2.2e-08 1.4e-01 93 GLTP
80 12 111102574 113517494 15 1 3.8e-21 7.3e-29 3.4e-11 65 SH2B3
81 12 121146219 123131824 3 3 1.7e-15 3.1e-15 1.0e+00 100 KDM2B RNF34 WDR66
82 13 29641514 31108727 1 1 2.7e-09 2.2e-10 1.8e-02 86 UBL3
83 15 40360741 42749023 8 1 4.6e-11 2.9e-11 1.0e-01 94 CHP1
84 15 67138238 68789191 1 1 8.9e-08 1.7e-08 3.2e-02 86 MAP2K5
85 15 73933444 76108550 12 8 2.4e-23 7.1e-23 1.0e+00 100 ARID3B COX5A CSK CYP11A1 MPI RPP25 ULK3
86 15 80377452 81936479 1 1 6.9e-14 1.2e-14 4.7e-02 93 KIAA1199
87 15 90712555 92187978 3 1 9.6e-33 8.7e-29 3.0e-01 99 FES
88 16 3025993 5441125 3 3 8.6e-11 1.8e-09 2.7e-06 39 AC006111.1 MGRN1
89 16 29412503 31892919 14 2 7.1e-10 3.2e-09 4.0e-02 88 DOC2A KAT8
90 16 69337091 70978362 4 1 4.0e-08 5.0e-07 1.0e+00 100 AARS
91 16 74778006 76197034 1 1 1.5e-07 5.7e-06 9.5e-01 100 TMEM170A
92 16 89013848 90172696 8 1 7.0e-13 9.0e-13 1.0e-01 95 CDK10
93 17 1517914 2918626 1 1 1.2e-07 1.3e-08 1.1e-03 67 SRR
94 17 3208350 4766937 2 1 3.1e-09 1.2e-08 3.5e-01 97 RP11-810M2.2
95 17 6202301 8484683 10 4 8.2e-12 6.7e-12 9.8e-01 100 ALOX12 LSMD1 SENP3 SLC2A4
96 17 44788310 45597098 2 1 1.3e-07 2.9e-12 4.2e-12 2 WNT3
97 17 45921906 47718188 6 2 2.6e-11 2.4e-15 1.8e-13 14 HOXB2 RP11-463M16.4
98 17 60858059 62279811 1 1 9.5e-15 1.3e-15 1.0e+00 100 ACE
99 17 73175294 74629867 4 1 1.2e-08 1.9e-08 2.0e-01 95 FBF1
100 19 1163934 2560423 2 2 1.4e-09 1.5e-09 1.0e+00 100 CTB-31O20.6 KLF16
101 19 16462417 18007950 3 1 1.5e-12 1.7e-13 1.3e-04 73 MYO9B
102 19 49148143 50557876 1 1 1.7e-07 7.6e-07 2.4e-02 79 TEAD2
103 20 7419920 9648826 1 1 2.2e-09 3.4e-19 2.6e-11 44 PLCB1
104 20 29927166 31615615 3 2 8.1e-09 8.8e-08 7.0e-06 29 C20orf160 TSPY26P
105 20 42040938 43508687 1 1 8.2e-08 2.4e-11 5.0e-06 53 JPH2
106 20 56858751 58262841 2 1 1.5e-09 1.4e-33 1.8e-27 19 NELFCD
107 20 61522825 62912463 7 7 2.5e-12 4.7e-12 1.0e+00 100 LIME1 OPRL1 RGS19 TPD52L2 ZBTB46
108 21 44512286 45879403 1 1 7.0e-08 2.5e-08 1.0e+00 100 PDXK
109 22 28792887 30261219 1 1 6.3e-08 6.7e-08 1.0e-02 77 KREMEN1

Pleiotropic Associations

Trait chisq ratio # genes+ # genes++ % genes++ corr corr P genes
Alzheimer’s Disease (in mother) 1.25 1 0 0.0 0.00 1.0e+00 KAT8
Alzheimer’s Disease (including proxy) 1.60 4 2 6.1 0.99 6.9e-03 ACE KAT8 PRKD3 PVRIG
Crohns Disease (2017) 1.40 3 2 6.1 0.00 1.0e+00 PDLIM4 PMS2P5 RP11-436D10.3
Irritable Bowel Disease (IBD) 1.42 3 2 6.1 0.00 1.0e+00 PDLIM4 PMS2P5 RP11-436D10.3
Ulcerative Colitis (UC) 1.29 2 0 0.0 -0.78 2.2e-01 OPRL1 RGS19
Major Depression (MDD) 1.18 1 0 0.0 0.00 1.0e+00 FES
Reaction Time 1.18 1 1 3.0 0.00 1.0e+00 SH2B3
Verbal and Numeric Reasoning (VNR) 0.99 2 1 3.0 0.00 1.0e+00 DCAF16 TEX15
Breast Cancer 2.30 10 4 12.1 -0.34 3.4e-01 CSK FES PDLIM4 PMS2P5 RGS19 RP11-436D10.3 SIK2 SIPA1 SLC4A7 TNNT3
Ovarian Cancer 1.22 2 0 0.0 0.00 1.0e+00 HOXB2 WNT3
Prostate Cancer 1.41 2 1 3.0 0.00 1.0e+00 RUVBL1 TNNT3
Body Mass Index (BMI) (2010) 1.80 2 1 3.0 0.00 1.0e+00 MAP2K5 STAG3L1
Coronary Artery Disease (CAD) 2.06 3 2 6.1 0.00 1.0e+00 DBR1 RP11-463M16.4 SH2B3
Crohns Disease (2012) 1.27 2 1 3.0 0.00 1.0e+00 PDLIM4 RP11-436D10.3
Fasting Glucose 1.56 1 1 3.0 0.00 1.0e+00 ACP2
HDL Cholesterol 1.39 4 1 3.0 1.00 3.8e-03 ACP2 NRBF2 PIGV SIPA1
LDL Cholesterol 1.51 3 0 0.0 0.00 1.0e+00 PIGV SH2B3 TIRAP
Neuroticism 1.26 2 0 0.0 0.00 1.0e+00 MSRA NEIL2
Primary Biliary Cirrhosis 1.20 2 1 3.0 0.00 1.0e+00 CISD2 SH2B3
Rheumatoid Arthritis 1.12 1 0 0.0 0.00 1.0e+00 SH2B3
Schizophrenia 1.58 5 2 6.1 -0.22 7.2e-01 CERS5 DOC2A FES NT5C2 RP5-1115A15.1
Triglycerides 1.44 3 1 3.0 0.50 5.0e-01 KAT8 NEIL2 NRBF2
Type 2 Diabetes (T2D) 1.76 1 0 0.0 0.00 1.0e+00 HOXB2
Blood Eosinophil Count 3.00 18 12 36.4 -0.59 9.9e-03 CD164L2 CERS5 DOC2A FBF1 FLJ13197 GLTP KAT8 NDUFAF6 PDLIM4 PDXK PIGV RP5-1115A15.1 SH2B3 SIK2 SLC2A4 TIRAP TSPY26P WNT3
Blood Platelet Count 2.90 45 32 97.0 0.13 3.8e-01 ABCF3 AGTRAP C20orf160 C3orf63 CDK10 CERS5 CLCN6 COX5A CSK DCAF16 FBF1 FLJ13197 GTF2B KCNJ11 KIF2A KREMEN1 LFNG LIME1 MFN2 MGRN1 MPI MYO9B NELFCD NRBF2 PDLIM4 PHIP PIGV RP11-436D10.3 RP11-463M16.4 RPP25 RUVBL1 SENP1 SH2B3 SIK2 SIPA1 SLC4A7 SWAP70 TBC1D12 TIRAP TMEM170A TNKS1BP1 TNNT3 USP37 WNT2B ZNF318
Blood Red Count 1.80 41 26 78.8 -0.31 4.4e-02 ARID3B C20orf160 C3orf63 C4orf22 C6orf174 CDK10 CENPW CLCN6 COX5A CSK CYP11A1 DOC2A FBF1 FLJ13197 GTF2B JPH2 KAT8 LSMD1 MAP2K5 MGRN1 MPI NCOA1 NDUFAF6 NELFCD NPPA-AS1 NRBF2 NT5C2 PDXK PVRIG RPP25 SENP1 SH2B3 SIPA1 SLC35F6 TBC1D12 TDRD1 TSPY26P UBE2E3 ULK3 USP37 WNT3
Blood White Count 2.07 22 12 36.4 -0.46 2.9e-02 CDK10 CERS5 DCAF16 FES FLJ13197 GTF2B KAT2B KB-1107E3.1 KCNK3 LSMD1 MED21 MGRN1 NRBF2 NT5C2 PDLIM4 RP5-1115A15.1 SH2B3 SRR TBC1D12 TEX15 TMEM133 UBE2E3
Heel T-Score 2.01 28 23 69.7 0.22 2.6e-01 ACP2 ATG7 C20orf160 C6orf174 DCAF16 DOC2A FLJ13197 GTF2B KAT8 KREMEN1 LFNG LSMD1 NCOA1 NELFCD NT5C2 PDE1A PMS2P5 RP11-810M2.2 RP4-635E18.7 RP5-1115A15.1 SENP3 SIPA1 SLC2A4 TMEM133 UBE2E3 WNT2B WNT3 ZNF318
BMI 2.39 41 25 75.8 -0.56 9.0e-05 AARS AC006111.1 C20orf160 C4orf22 CEP41 CHP1 CISD2 COX5A CTB-31O20.6 DOC2A EXOC4 FBF1 FLJ13197 KAT8 KB-1107E3.1 KCNJ11 KCNK3 KDM2B KIAA1199 KLF16 MAP2K5 NRBF2 NT5C2 PMS2P5 RGS19 RNF34 RP11-463M16.4 RP11-538P18.2 RP11-613D13.5 RP4-758J18.10 RP5-1115A15.1 RPP25 SIPA1 SRR STAG3L1 TDRD1 TEAD2 TEX15 TSPY26P USP37 ZNF318
Height 1.72 52 42 127.3 0.33 1.6e-02 AC006111.1 ACE ACP2 C1orf50 C20orf160 CCDC112 CENPW CERS5 CHP1 CYP11A1 DBR1 DCAF16 DOC2A FES GOPC GTF2B HOXB2 HRCT1 KCNJ11 MGRN1 NCOA1 NPR3 NRBF2 NT5C2 PDE1A PDLIM4 PIGV PRELID1P1 PTPN12 RP11-436D10.3 RP11-463M16.4 RP11-538P18.2 RP11-810M2.2 RP4-635E18.7 RP5-1115A15.1 RYK SENP3 SH2B3 SIPA1 SLC35F6 SLC4A7 STAG3L1 TBC1D12 TMEM133 TMEM170A TNKS1BP1 TNNT3 USP37 WDR66 WNT2B WNT3 ZNF318
Waist Hip Ratio (WHR) 1.84 21 11 33.3 -0.37 8.6e-02 C6orf174 CENPW CEP41 CYP11A1 DBR1 DOC2A GTF2B KCNJ11 KREMEN1 MYO9B NCOA1 OPRL1 PRELID1P1 PTPN12 RGS19 SIK2 SIPA1 SWAP70 TBC1D19 WNT3 ZNF318
Systolic Blood Pressure 11.65 117 96 290.9 -0.96 1.4e-73 AARS ABCF3 AC006111.1 ACE ACP2 AGT AGTRAP AKR1B1 ALOX12 AQP5 ARID3B ATG7 ATP2B1 C1GALT1 C20orf160 C3orf63 C4orf22 C6orf174 CCDC112 CD164L2 CENPW CERS5 CHP1 CLCN6 COX5A CSK CTB-31O20.6 CWF19L2 CYP11A1 DBR1 DCAF16 DRAXIN ENPEP FBF1 FCF1P2 FES FLJ13197 GLTP GOPC GTF2B HOXB2 HRCT1 JPH2 KAT2B KB-1107E3.1 KCNJ11 KDM2B KIAA1199 KIF2A KLF16 KREMEN1 LDB3 LFNG LIME1 LSMD1 MED21 MFN2 MGRN1 MPI MYO9B NCOA1 NDUFAF6 NEIL2 NELFCD NOC3L NPPA-AS1 NPR3 NRBF2 NSUN6 NT5C2 OPRL1 PDE1A PDXK PHIP PIGV PLCB1 PMS2P5 PRDM8 PRELID1P1 PRKD3 PTPN12 RGS19 RNF34 RP11-436D10.3 RP11-463M16.4 RP11-538P18.2 RP11-588K22.2 RP4-635E18.7 RP4-758J18.10 RP5-1115A15.1 RPP25 RUVBL1 RYK SENP1 SENP3 SH2B3 SIK2 SIPA1 SLC2A4 SLC4A7 SRR STAG3L1 SWAP70 TBC1D12 TBC1D19 TMEM133 TMEM170A TNNT3 TPD52L2 UBL3 UFL1 ULK3 WDR66 WNT2B WNT3 ZBTB46 ZNF318
Smoking Status 1.25 6 0 0.0 -0.18 7.3e-01 FES KIAA1199 MAP2K5 RP11-463M16.4 RP5-1115A15.1 SRR
Allergy or Eczema 1.86 11 3 9.1 -0.13 7.0e-01 CHP1 CLCN6 LIME1 NRBF2 PDLIM4 PDXK RNF34 RP5-1115A15.1 SIK2 SRR ULK3
Cardiovascular Disease 11.87 135 105 318.2 -0.99 3.4e-121 AARS ABCF3 AC006111.1 ACE ACP2 AGT AGTRAP AKR1B1 AQP5 ARID3B ATG7 ATP2B1 C1GALT1 C1orf50 C20orf160 C4orf22 C6orf174 CAND1 CCDC112 CD164L2 CDK10 CENPW CEP41 CERS5 CHP1 CISD2 CLCN6 COX5A CSK CTB-31O20.6 CWF19L2 CYP11A1 DBR1 DCAF16 DOC2A DRAXIN ENPEP EXOC4 FBF1 FCF1P2 FES FLJ13197 GLTP GOPC GTF2B HOXB2 HRCT1 JARID2 KAT2B KAT8 KB-1107E3.1 KCNJ11 KCNK3 KDM2B KIAA1199 KIF2A KLF16 KREMEN1 LDB3 LFNG LIME1 LSMD1 MAP2K5 MED21 MFN2 MGRN1 MPI MYO9B NCOA1 NDUFAF6 NELFCD NGF NOC3L NPPA-AS1 NPR3 NRBF2 NSUN6 NT5C2 OPRL1 OSGIN2 PDE1A PDXK PHIP PIGV PLCB1 PMS2P5 PRDM8 PRELID1P1 PTPN12 PVRIG RGS19 RNF34 RP11-436D10.3 RP11-463M16.4 RP11-538P18.2 RP11-588K22.2 RP11-613D13.5 RP11-810M2.2 RP4-635E18.7 RP4-758J18.10 RP5-1115A15.1 RPP25 RYK SENP1 SENP3 SH2B3 SIK2 SIPA1 SLC2A4 SLC35F6 SLC4A7 SRR STAG3L1 SWAP70 TBC1D12 TBC1D19 TDRD1 TEAD2 TEX15 TMEM133 TMEM170A TNKS1BP1 TNNT3 TPD52L2 TSPY26P UBL3 UFL1 ULK3 USP37 VANGL1 WDR66 WNT2B YEATS4 ZBTB46 ZNF318
Hypothyroidism (self reported) 1.73 2 2 6.1 0.00 1.0e+00 RP5-1115A15.1 SH2B3
Respiratory disease 1.60 5 3 9.1 -0.64 2.5e-01 CHP1 PDLIM4 RP5-1115A15.1 RUVBL1 SIK2
Type 2 Diabetes (T2D) 2.23 9 5 15.2 -0.74 2.2e-02 ACE DBR1 KCNJ11 NDUFAF6 PMS2P5 PRELID1P1 SH2B3 SIPA1 ZBTB46
Lung FEV1/FVC ratio 1.94 20 14 42.4 0.35 1.2e-01 ATG7 ATP2B1 C1GALT1 C3orf63 CENPW CEP41 CTB-31O20.6 GOPC KB-1107E3.1 NRBF2 PDLIM4 PVRIG RP11-436D10.3 RP11-810M2.2 RP5-1115A15.1 RUVBL1 TMEM133 TMEM170A TSPY26P WNT3
Lung FVC 1.57 19 11 33.3 0.07 7.7e-01 C1GALT1 CHP1 DBR1 DCAF16 HOXB2 KAT8 MAP2K5 NCOA1 NRBF2 NT5C2 OPRL1 PDLIM4 RGS19 RP11-538P18.2 RP11-613D13.5 SH2B3 WNT2B WNT3 ZBTB46
Neuroticism 1.13 5 3 9.1 -0.03 9.6e-01 ACP2 MAP2K5 NT5C2 RP5-1115A15.1 WNT3
Chronotype (morning person) 1.10 2 0 0.0 0.00 1.0e+00 RP11-810M2.2 RP5-1115A15.1
Hair Pigment 3.20 18 10 30.3 -0.18 4.5e-01 ACP2 ATP2B1 C20orf160 C4orf22 CDK10 DBR1 FES FLJ13197 HOXB2 KIF2A OPRL1 PIGV RGS19 RP5-1115A15.1 SH2B3 SIPA1 TSPY26P WNT3
Tanning 3.56 6 4 12.1 0.62 1.9e-01 CDK10 NRBF2 RP11-436D10.3 SH2B3 TSPY26P ULK3
Hand grip strength (left) 1.46 5 2 6.1 -0.86 5.9e-02 DCAF16 FES HOXB2 MGRN1 PDLIM4
Number of treatments/medications taken 3.68 10 4 12.1 0.97 2.2e-06 ACE CHP1 CISD2 CWF19L2 DCAF16 FLJ13197 KIAA1199 SH2B3 TMEM133 TNKS1BP1
Sensitivity / hurt feelings 1.12 2 1 3.0 0.00 1.0e+00 FES WNT3
Frequency of depressed mood in last 2 weeks 1.03 1 0 0.0 0.00 1.0e+00 RP5-1115A15.1
Hearing difficulty/problems: Yes 1.13 1 1 3.0 0.00 1.0e+00 ZNF318
Relative age of first facial hair 1.30 5 4 12.1 -0.69 2.0e-01 AARS ATG7 C4orf22 NRBF2 WNT3
Systolic blood pressure, automated reading 8.56 79 55 166.7 0.98 9.4e-61 AARS AC006111.1 ACP2 AGT AGTRAP AQP5 ATG7 ATP2B1 C3orf63 C4orf22 C6orf174 CERS5 CHP1 CLCN6 COX5A CSK CTB-31O20.6 CWF19L2 DCAF16 DRAXIN FCF1P2 FES FLJ13197 GLTP GOPC GTF2B HOXB2 KCNJ11 KIAA1199 KIF2A KLF16 LFNG LIME1 MED21 MFN2 MGRN1 MPI MSRA MYO9B NCOA1 NEIL2 NELFCD NOC3L NPPA-AS1 NPR3 NRBF2 NSUN6 NT5C2 OPRL1 PHIP PIGV PMS2P5 PRELID1P1 PRKD3 RGS19 RP11-436D10.3 RP11-538P18.2 RP11-588K22.2 RP4-635E18.7 RP5-1115A15.1 RPP25 SENP3 SH2B3 SIPA1 SLC2A4 SLC4A7 SRR STAG3L1 SWAP70 TBC1D12 TMEM133 TMEM170A TNNT3 TPD52L2 UFL1 ULK3 WNT2B WNT3 ZBTB46
Angina 2.45 5 1 3.0 0.97 5.0e-03 FES OPRL1 RGS19 RP11-463M16.4 TPD52L2
Supplements: Zinc 1.23 1 1 3.0 0.00 1.0e+00 NRBF2
Medication: Metformin 1.78 4 0 0.0 1.00 1.3e-03 CISD2 DBR1 KCNJ11 PMS2P5
Pack years adult smoking proportion 1.22 1 0 0.0 0.00 1.0e+00 PMS2P5
Impedance of leg (right) 2.19 38 20 60.6 -0.13 4.2e-01 ABCF3 ATG7 CEP41 CERS5 CTB-31O20.6 DOC2A FES JPH2 KAT8 KCNJ11 KCNK3 KIAA1199 KLF16 MAP2K5 MSRA MYO9B NEIL2 NELFCD NOC3L NT5C2 PMS2P5 PRKD3 RGS19 RP11-463M16.4 RP4-758J18.10 RYK SENP1 SENP3 SLC35F6 SRR STAG3L1 SWAP70 TBC1D12 TMEM133 USP37 WDR66 WNT2B ZNF318
Leg fat-free mass (left) 1.90 28 13 39.4 0.18 3.6e-01 ABCF3 CENPW CTB-31O20.6 DCAF16 DOC2A FES KAT8 KCNK3 KIAA1199 KLF16 MAP2K5 MSRA NEIL2 NPR3 NT5C2 PDE1A PDLIM4 PRELID1P1 RP11-436D10.3 RP11-613D13.5 SH2B3 SLC35F6 SRR STAG3L1 TDRD1 TEAD2 ULK3 WDR66
Trunk fat percentage 1.97 24 10 30.3 0.66 4.2e-04 AARS CDK10 CHP1 COX5A CTB-31O20.6 DBR1 DOC2A KAT8 KCNK3 KDM2B MAP2K5 MYO9B NOC3L RNF34 RP11-613D13.5 RP11-810M2.2 RP5-1115A15.1 SENP3 SRR STAG3L1 TBC1D12 TEX15 WNT2B WNT3
Hand grip strength (right) 1.48 5 3 9.1 -0.93 2.1e-02 DCAF16 HOXB2 JARID2 PDLIM4 WNT2B
Townsend deprivation index at recruitment 1.29 2 0 0.0 0.00 1.0e+00 KLF16 MAP2K5
Current tobacco smoking 1.34 1 0 0.0 0.00 1.0e+00 MSRA
Maternal smoking around birth 1.28 1 0 0.0 0.00 1.0e+00 C20orf160
Fed-up feelings 1.14 2 1 3.0 0.00 1.0e+00 SH2B3 TEX15
Relative age voice broke 1.10 3 0 0.0 0.00 1.0e+00 NRBF2 RP11-613D13.5 WNT3
Taking other prescription medications 1.98 5 1 3.0 1.00 1.4e-04 CHP1 CISD2 PMS2P5 SH2B3 ZNF318
Age when periods started (menarche) 1.65 8 5 15.2 -0.50 2.1e-01 CTB-31O20.6 KLF16 MAP2K5 NRBF2 PMS2P5 RP11-613D13.5 SIPA1 STAG3L1
Heel bone mineral density (BMD) T-score, automated (left) 1.85 9 6 18.2 -0.17 6.7e-01 ACP2 C6orf174 KREMEN1 LSMD1 MSRA NEIL2 RP5-1115A15.1 SIPA1 WNT2B
Hayfever, allergic rhinitis or eczema 1.79 4 4 12.1 0.50 5.0e-01 CHP1 PDLIM4 RP5-1115A15.1 SIK2
Multivitamins +/- minerals 1.29 1 0 0.0 0.00 1.0e+00 NRBF2
Supplements: Glucosamine 1.75 2 1 3.0 0.00 1.0e+00 CSK NRBF2
Medication: Atenolol 4.85 4 2 6.1 0.99 1.4e-02 FES PRKD3 SH2B3 TMEM133
Medication: Levothyroxine sodium 1.59 2 1 3.0 0.00 1.0e+00 MSRA SH2B3
Sitting height 1.37 20 13 39.4 -0.24 3.1e-01 C20orf160 CENPW CERS5 CHP1 DCAF16 GOPC GTF2B JARID2 KIAA1199 NPR3 PDLIM4 PRELID1P1 RP11-436D10.3 RP11-463M16.4 RP11-538P18.2 SLC35F6 SLC4A7 TBC1D12 WDR66 WNT3
High blood pressure (mother) 5.01 13 3 9.1 0.97 2.0e-08 AGT C4orf22 C6orf174 CENPW CLCN6 FES KCNJ11 NT5C2 PIGV SENP1 SLC4A7 TMEM170A TNNT3
Body mass index (BMI) 2.48 32 17 51.5 0.61 1.8e-04 AARS CEP41 COX5A CTB-31O20.6 CYP11A1 DOC2A EXOC4 GTF2B KAT8 KCNJ11 KCNK3 KDM2B KIAA1199 KLF16 MAP2K5 MSRA NEIL2 NRBF2 NT5C2 PMS2P5 RGS19 RP11-613D13.5 RP5-1115A15.1 RPP25 SIPA1 SRR STAG3L1 TDRD1 TEAD2 TEX15 ULK3 USP37
Impedance of leg (left) 2.22 35 22 66.7 -0.20 2.4e-01 AARS ABCF3 ATG7 CEP41 CERS5 CTB-31O20.6 DOC2A FES JPH2 KAT8 KCNJ11 KCNK3 KIAA1199 KLF16 MAP2K5 MSRA MYO9B NEIL2 NELFCD NOC3L NT5C2 PMS2P5 PRKD3 RGS19 RP11-463M16.4 RP4-758J18.10 SLC35F6 SRR STAG3L1 SWAP70 TBC1D12 TMEM133 USP37 WNT2B ZNF318
Leg predicted mass (left) 1.89 27 13 39.4 0.27 1.8e-01 ABCF3 CENPW CTB-31O20.6 DCAF16 DOC2A KAT8 KCNK3 KIAA1199 KLF16 MAP2K5 MSRA MYO9B NEIL2 NPR3 NT5C2 PDE1A PDLIM4 PRELID1P1 RP11-436D10.3 RP11-613D13.5 SLC35F6 SRR STAG3L1 TDRD1 TEAD2 ULK3 WDR66
Trunk fat mass 1.97 24 9 27.3 0.57 3.4e-03 AARS COX5A CTB-31O20.6 DBR1 DOC2A KAT8 KB-1107E3.1 KCNK3 KDM2B KIAA1199 KLF16 MAP2K5 NT5C2 RNF34 RP11-613D13.5 RP11-810M2.2 RP5-1115A15.1 RPP25 SRR STAG3L1 TDRD1 TEAD2 TEX15 WNT2B
Waist circumference 2.31 27 11 33.3 0.51 6.5e-03 AARS COX5A CSK CTB-31O20.6 CYP11A1 DOC2A EXOC4 KAT8 KB-1107E3.1 KCNK3 KDM2B KIAA1199 KLF16 MAP2K5 MPI NRBF2 PHIP RP11-613D13.5 RP11-810M2.2 RPP25 SIPA1 SRR STAG3L1 TDRD1 TEAD2 TEX15 ULK3
Number of incorrect matches in round 1.20 3 0 0.0 0.00 1.0e+00 DOC2A JARID2 KAT8
Past tobacco smoking 1.38 4 1 3.0 -0.66 3.4e-01 AQP5 MAP2K5 SH2B3 SRR
Alcohol usually taken with meals 1.26 1 0 0.0 0.00 1.0e+00 NRBF2
Nervous feelings 1.25 4 1 3.0 -0.61 3.9e-01 KAT8 MSRA NEIL2 NT5C2
Frequency of tenseness / restlessness in last 2 weeks 1.04 1 0 0.0 0.00 1.0e+00 NT5C2
Hearing difficulty/problems with background noise 1.38 3 1 3.0 0.00 1.0e+00 CSK ULK3 ZNF318
Hair/balding pattern: Pattern 2 1.35 2 1 3.0 0.00 1.0e+00 C4orf22 PRDM8
Had menopause 1.09 1 0 0.0 0.00 1.0e+00 CHP1
Forced vital capacity (FVC) 1.60 10 4 12.1 -0.37 3.0e-01 ACP2 CENPW DCAF16 HOXB2 KAT8 NCOA1 RP11-538P18.2 WDR66 WNT2B WNT3
Heel bone mineral density (BMD) T-score, automated (right) 1.82 9 6 18.2 -0.12 7.6e-01 ACP2 C6orf174 DCAF16 KREMEN1 LSMD1 MSRA NEIL2 RP5-1115A15.1 WNT2B
Qualifications: None of the above 1.49 3 1 3.0 0.00 1.0e+00 EXOC4 NRBF2 PHIP
Mouth/teeth dental problems 1.39 2 0 0.0 0.00 1.0e+00 PMS2P5 SIPA1
Heart attack 2.08 1 1 3.0 0.00 1.0e+00 FES
Allergy 1.82 6 4 12.1 -0.17 7.5e-01 CHP1 FES LIME1 PDLIM4 RP5-1115A15.1 SIK2
Diabetes (self-reported) 2.13 3 2 6.1 0.00 1.0e+00 KCNJ11 PMS2P5 ZBTB46
Medication: Ramipril 4.40 6 2 6.1 0.97 1.7e-03 CISD2 CSK CYP11A1 FES GOPC TMEM133
Medication: Simvastatin 3.54 6 3 9.1 0.81 1.5e-02 FES OPRL1 PIGV RGS19 SIPA1 TMEM133
Fluid intelligence score 1.11 2 1 3.0 0.00 1.0e+00 DCAF16 KCNJ11
Illnesses of siblings 3.64 8 0 0.0 -0.97 6.0e-05 FES FLJ13197 KAT8 NRBF2 PRELID1P1 SH2B3 TMEM133 YEATS4
Neuroticism score 1.12 4 3 9.1 -0.99 1.2e-02 MSRA NEIL2 RP5-1115A15.1 WNT3
Weight 2.04 30 14 42.4 0.42 2.2e-02 AARS C1orf50 CTB-31O20.6 DCAF16 DOC2A EXOC4 FLJ13197 KAT8 KB-1107E3.1 KCNK3 KIAA1199 KLF16 MAP2K5 MSRA NEIL2 NT5C2 PDLIM4 RP11-436D10.3 RP11-613D13.5 RP11-810M2.2 RPP25 SH2B3 SRR STAG3L1 TDRD1 TEAD2 TIRAP ULK3 WDR66 WNT2B
Impedance of arm (right) 2.05 34 14 42.4 -0.27 1.2e-01 CEP41 CERS5 CISD2 CTB-31O20.6 CYP11A1 DOC2A EXOC4 KAT8 KCNJ11 KIAA1199 KLF16 KREMEN1 LIME1 MAP2K5 MSRA MYO9B NEIL2 NOC3L NRBF2 PDE1A PRKD3 RGS19 RP11-463M16.4 RYK SENP1 SENP3 SLC4A7 STAG3L1 SWAP70 TBC1D12 TNNT3 TSPY26P ULK3 WNT2B
Arm fat percentage (right) 2.17 27 13 39.4 0.79 1.1e-06 AARS CHP1 COX5A CTB-31O20.6 DCAF16 DOC2A FBF1 KAT8 KCNK3 KDM2B KLF16 MAP2K5 MSRA NT5C2 PMS2P5 RNF34 RP11-613D13.5 RP11-810M2.2 RP5-1115A15.1 SENP3 SIPA1 SLC2A4 SRR STAG3L1 TDRD1 TEAD2 TEX15
Trunk fat-free mass 1.87 27 14 42.4 -0.06 7.5e-01 CCDC112 CENPW DCAF16 DOC2A JARID2 KAT8 KCNK3 KIAA1199 KLF16 LIME1 MYO9B NCOA1 NPR3 NT5C2 PDE1A PDLIM4 PRELID1P1 RP11-436D10.3 SENP3 SH2B3 SLC35F6 SLC4A7 TBC1D12 TEAD2 TMEM133 ULK3 WDR66
Hip circumference 2.09 25 12 36.4 0.39 5.1e-02 AARS CCDC112 CLCN6 CTB-31O20.6 DCAF16 DOC2A KAT8 KB-1107E3.1 KCNK3 KIAA1199 KLF16 MAP2K5 MSRA NPPA-AS1 NT5C2 PHIP PMS2P5 RGS19 RP11-436D10.3 RP11-613D13.5 RP11-810M2.2 SH2B3 SRR STAG3L1 WDR66
Alcohol intake versus 10 years previously 1.16 1 0 0.0 0.00 1.0e+00 DOC2A
Father's age at death 2.11 2 2 6.1 0.00 1.0e+00 FES SH2B3
Worrier / anxious feelings 1.51 4 1 3.0 -0.60 4.0e-01 KAT8 MSRA NEIL2 NT5C2
Frequency of tiredness / lethargy in last 2 weeks 1.16 1 0 0.0 0.00 1.0e+00 RP5-1115A15.1
Hair/balding pattern: Pattern 3 1.51 3 2 6.1 0.00 1.0e+00 C4orf22 PRDM8 WNT3
Forced expiratory volume in 1-second (FEV1) 1.74 14 3 9.1 -0.34 2.3e-01 DCAF16 GOPC HOXB2 KAT8 MSRA NCOA1 NRBF2 PDLIM4 RP11-538P18.2 RUVBL1 TMEM133 TSPY26P UBE2E3 WNT3
Qualifications: A levels/AS levels or equivalent 1.33 4 0 0.0 -1.00 1.3e-03 DCAF16 EXOC4 NRBF2 STAG3L1
Mouth/teeth dental problems: Dentures 1.16 1 0 0.0 0.00 1.0e+00 EXOC4
Asthma 1.69 4 3 9.1 0.48 5.2e-01 PDLIM4 RP5-1115A15.1 RUVBL1 SIK2
Medication: Cholesterol lowering 3.72 9 4 12.1 0.93 3.8e-05 CHP1 FES OPRL1 PIGV PVRIG RGS19 SIPA1 TIRAP TMEM133
Depression (self-reported) 1.10 1 1 3.0 0.00 1.0e+00 RP5-1115A15.1
Illnesses of mother 3.23 2 1 3.0 0.00 1.0e+00 AGT FES
Forced expiratory volume in 1-second (FEV1), Best measure 1.74 11 5 15.2 -0.35 2.9e-01 AQP5 DCAF16 KAT8 MSRA NCOA1 NRBF2 PDLIM4 RP11-538P18.2 RUVBL1 TMEM133 WNT3
Pulse wave Arterial Stiffness index 1.65 1 0 0.0 0.00 1.0e+00 DRAXIN
Impedance of arm (left) 2.07 33 13 39.4 -0.15 3.9e-01 CERS5 CISD2 CYP11A1 DOC2A EXOC4 KAT8 KCNJ11 KIAA1199 KLF16 KREMEN1 LIME1 MAP2K5 MSRA MYO9B NEIL2 NOC3L NRBF2 OPRL1 PDE1A PRKD3 RGS19 RP11-463M16.4 RYK SENP1 SENP3 SH2B3 SLC4A7 STAG3L1 TBC1D12 TNNT3 TSPY26P ULK3 WNT2B
Arm fat mass (right) 2.22 25 11 33.3 0.68 1.9e-04 AARS COX5A CTB-31O20.6 DOC2A KAT8 KB-1107E3.1 KCNK3 KDM2B KIAA1199 KLF16 MAP2K5 MSRA NT5C2 PMS2P5 RP11-613D13.5 RP11-810M2.2 RP5-1115A15.1 RPP25 SIPA1 SRR STAG3L1 TDRD1 TEAD2 TEX15 ULK3
Trunk predicted mass 1.87 27 13 39.4 -0.07 7.4e-01 CCDC112 CENPW DCAF16 DOC2A JARID2 KAT8 KCNK3 KIAA1199 KLF16 LIME1 MYO9B NCOA1 NPR3 NT5C2 PDE1A PDLIM4 PRELID1P1 RP11-436D10.3 SENP3 SH2B3 SLC35F6 SLC4A7 TBC1D12 TEAD2 TMEM133 ULK3 WDR66
Standing height 1.69 36 22 66.7 -0.35 3.4e-02 AC006111.1 ACP2 CENPW CERS5 CHP1 DCAF16 DOC2A GOPC GTF2B HOXB2 KCNJ11 MGRN1 MSRA NCOA1 NPR3 NRBF2 PDE1A PDLIM4 PIGV PRELID1P1 PTPN12 RP11-436D10.3 RP11-463M16.4 RP11-538P18.2 RP11-810M2.2 RP4-635E18.7 RP5-1115A15.1 RYK SH2B3 SIPA1 SLC35F6 TMEM170A USP37 WDR66 WNT2B ZNF318
Breastfed as a baby 1.04 1 0 0.0 0.00 1.0e+00 RP4-758J18.10
Tense / 'highly strung' 1.17 3 0 0.0 0.00 1.0e+00 KAT8 NT5C2 RP5-1115A15.1
Seen doctor (GP) for nerves, anxiety, tension or depression 1.32 1 0 0.0 0.00 1.0e+00 RP5-1115A15.1
Hair/balding pattern: Pattern 4 2.00 9 5 15.2 0.35 3.5e-01 C4orf22 CENPW CERS5 KAT2B PRDM8 PRELID1P1 RP5-1115A15.1 SRR WNT3
Birth weight of first child 2.92 15 5 15.2 -0.98 1.6e-12 AGTRAP CLCN6 COX5A CSK DCAF16 FES GTF2B MPI NPPA-AS1 RGS19 RPP25 SH2B3 STAG3L1 TBC1D12 TMEM170A
Peak expiratory flow (PEF) 1.49 5 2 6.1 -0.66 2.2e-01 C1GALT1 DCAF16 MSRA TMEM170A WNT3
Medication: Paracetamol 1.56 1 0 0.0 0.00 1.0e+00 UFL1
Headache pain in last month 1.53 4 1 3.0 -0.24 7.6e-01 MAP2K5 TMEM170A UFL1 WNT3
Medication for cholesterol, blood pressure or diabetes 7.25 33 14 42.4 -0.98 7.9e-24 AARS ACE ATP2B1 C1GALT1 C4orf22 CHP1 CISD2 CLCN6 CSK DRAXIN FCF1P2 FES FLJ13197 JARID2 KIAA1199 LFNG NGF OPRL1 OSGIN2 PDXK PLCB1 PVRIG RGS19 RP11-588K22.2 SENP1 SH2B3 SIK2 SIPA1 SLC4A7 TMEM133 TSPY26P WNT2B ZBTB46
Gout (self-reported) 1.54 1 0 0.0 0.00 1.0e+00 SH2B3
Hypothyroidism/myxoedema (self-reported) 1.58 3 1 3.0 0.00 1.0e+00 MSRA RP5-1115A15.1 SH2B3
Medication: Amlodipine 6.27 20 11 33.3 0.97 4.2e-14 C6orf174 CD164L2 CLCN6 FES FLJ13197 KCNK3 KDM2B KIAA1199 NPPA-AS1 OSGIN2 RNF34 RP4-635E18.7 SENP1 SENP3 SLC35F6 SLC4A7 TMEM133 TNNT3 WNT2B ZNF318
Birth weight 2.11 7 6 18.2 -0.63 1.3e-01 DCAF16 FES SH2B3 SIK2 SLC2A4 SRR TNNT3
High blood pressure (siblings) 4.59 10 4 12.1 0.96 1.2e-05 ACP2 C1GALT1 CLCN6 FES KAT8 NRBF2 PRELID1P1 SH2B3 TMEM133 TNNT3
Forced vital capacity (FVC), Best measure 1.54 9 5 15.2 -0.35 3.5e-01 ACP2 CENPW DCAF16 HOXB2 KAT8 NCOA1 RP11-538P18.2 RP11-613D13.5 WNT3
Body fat percentage 2.12 29 11 33.3 0.71 1.4e-05 AARS CHP1 COX5A CTB-31O20.6 DBR1 DCAF16 DOC2A KAT8 KCNK3 KDM2B KLF16 MAP2K5 MSRA MYO9B NOC3L PMS2P5 RNF34 RP11-613D13.5 RP11-810M2.2 RP5-1115A15.1 RPP25 SENP3 SIPA1 SRR STAG3L1 TBC1D12 TEX15 WNT2B WNT3
Leg fat percentage (right) 2.24 24 12 36.4 0.75 2.0e-05 AARS CHP1 COX5A CTB-31O20.6 DCAF16 DOC2A GTF2B KAT8 KCNK3 KDM2B MAP2K5 MSRA NOC3L NRBF2 PKP4 RP11-613D13.5 RP11-810M2.2 RP5-1115A15.1 RPP25 SLC2A4 STAG3L1 TBC1D12 TEX15 WNT2B
Arm fat-free mass (right) 1.90 24 13 39.4 0.00 9.9e-01 CENPW DCAF16 DOC2A EXOC4 KAT8 KCNK3 KIAA1199 KLF16 LIME1 MAP2K5 MYO9B NEIL2 NPR3 NT5C2 PDE1A PDLIM4 PRELID1P1 RP11-436D10.3 SENP3 SH2B3 SLC35F6 STAG3L1 ULK3 WDR66
Comparative body size at age 10 1.81 11 6 18.2 0.19 5.8e-01 AQP5 ATG7 CERS5 DOC2A FCF1P2 KAT8 MAP2K5 MSRA SRR WNT2B ZNF318
Worry too long after embarrassment 1.27 1 0 0.0 0.00 1.0e+00 MSRA
Wheeze or whistling in the chest in last year 1.65 1 1 3.0 0.00 1.0e+00 SIK2
Age at first live birth 1.40 1 0 0.0 0.00 1.0e+00 DCAF16
Qualifications: College or University degree 1.20 8 3 9.1 -0.77 2.5e-02 DCAF16 DOC2A EXOC4 GTF2B PKP4 STAG3L1 TEX15 WNT3
Medication for pain relief, constipation, heartburn 1.72 4 1 3.0 -0.99 7.2e-03 C20orf160 KIAA1199 PRDM8 UFL1
Neck or shoulder pain in last month 1.34 1 0 0.0 0.00 1.0e+00 RP5-1115A15.1
Medication: Blood pressure 9.12 55 24 72.7 0.99 2.2e-48 ACE ACP2 ATP2B1 C1GALT1 C20orf160 C4orf22 CCDC112 CEP41 CISD2 CLCN6 CSK CWF19L2 CYP11A1 DCAF16 DRAXIN FCF1P2 FES FLJ13197 HOXB2 JARID2 KDM2B KIAA1199 KLF16 LDB3 LFNG MSRA NELFCD NGF NOC3L NPPA-AS1 OSGIN2 PDXK PLCB1 PRDM8 PRELID1P1 PVRIG RGS19 RNF34 RP11-463M16.4 RP11-810M2.2 RP4-635E18.7 SENP1 SENP3 SH2B3 SIK2 SLC2A4 SLC4A7 STAG3L1 TMEM133 TNNT3 TSPY26P ULK3 WDR66 WNT2B ZBTB46
Angina (self-reported) 2.41 4 1 3.0 0.98 2.2e-02 FES OPRL1 RGS19 RP11-463M16.4
Migraine (self-reported) 1.25 1 1 3.0 0.00 1.0e+00 UFL1
Medication: Allopurinol 1.63 3 1 3.0 0.00 1.0e+00 LSMD1 SH2B3 WDR66
Medication: Seretide 50 evohaler 1.24 1 0 0.0 0.00 1.0e+00 PDLIM4
Mean time to correctly identify matches 1.16 2 1 3.0 0.00 1.0e+00 RP11-810M2.2 SH2B3
Whole body fat mass 2.06 25 13 39.4 0.61 1.2e-03 AARS COX5A CTB-31O20.6 DBR1 DOC2A KAT8 KB-1107E3.1 KCNK3 KDM2B KIAA1199 KLF16 MAP2K5 MSRA NT5C2 PMS2P5 RP11-613D13.5 RP11-810M2.2 RP5-1115A15.1 RPP25 SRR STAG3L1 TDRD1 TEAD2 TEX15 WNT2B
Leg fat mass (right) 2.19 23 10 30.3 0.67 4.6e-04 AARS CTB-31O20.6 DOC2A KAT8 KB-1107E3.1 KCNK3 KDM2B KIAA1199 KLF16 MAP2K5 MSRA NT5C2 PMS2P5 RP11-613D13.5 RP11-810M2.2 RP5-1115A15.1 RPP25 STAG3L1 TEAD2 TEX15 TSPY26P ULK3 WNT2B
Arm predicted mass (right) 1.90 24 13 39.4 0.07 7.5e-01 CENPW DCAF16 DOC2A KAT8 KCNK3 KIAA1199 KLF16 LIME1 MAP2K5 MYO9B NEIL2 NPR3 PDE1A PDLIM4 PRELID1P1 RP11-436D10.3 SENP3 SH2B3 SLC35F6 SLC4A7 STAG3L1 TSPY26P ULK3 WDR66
Pulse rate, automated reading 1.15 4 1 3.0 -0.69 3.1e-01 ACP2 C4orf22 PVRIG SIK2
Alcohol intake frequency. 1.33 3 2 6.1 0.00 1.0e+00 KAT8 PMS2P5 TEX15
Comparative height size at age 10 1.67 20 13 39.4 -0.22 3.5e-01 CENPW DCAF16 DOC2A GTF2B KCNJ11 KIAA1199 NCOA1 NPR3 PDE1A PDLIM4 PIGV PRELID1P1 RP11-613D13.5 RP11-810M2.2 RP4-635E18.7 RP5-1115A15.1 RYK SH2B3 WDR66 WNT2B
Number of full sisters 1.44 1 0 0.0 0.00 1.0e+00 NRBF2
Suffer from 'nerves' 1.12 1 0 0.0 0.00 1.0e+00 RP5-1115A15.1
Overall health rating 1.96 7 5 15.2 0.98 1.1e-04 C1GALT1 KAT8 MSRA PMS2P5 SIPA1 TEX15 TSPY26P
Chest pain or discomfort 1.40 1 0 0.0 0.00 1.0e+00 KB-1107E3.1
Medication: Aspirin 3.53 7 2 6.1 0.96 5.9e-04 FES GOPC OPRL1 RGS19 RP11-463M16.4 SH2B3 SIK2
Hypertension (Self-reported) 13.53 148 127 384.8 1.00 1.2e-217 AARS ABCF3 AC006111.1 ACE ACP2 AGT AGTRAP AKR1B1 ALOX12 AQP5 ARID3B ATG7 ATP2B1 C1GALT1 C1orf50 C20orf160 C3orf63 C4orf22 C6orf174 CAND1 CCDC112 CD164L2 CDK10 CENPW CEP41 CERS5 CHP1 CISD2 CLCN6 COX5A CSK CTB-31O20.6 CWF19L2 CYP11A1 DBR1 DCAF16 DOC2A DRAXIN ENPEP EXOC4 FBF1 FCF1P2 FES FLJ13197 GLTP GOPC GTF2B HOXB2 HRCT1 JARID2 JPH2 KAT2B KAT8 KB-1107E3.1 KCNJ11 KCNK3 KDM2B KIAA1199 KIF2A KLF16 KREMEN1 LDB3 LFNG LIME1 LSMD1 MAP2K5 MED21 MFN2 MGRN1 MPI MSRA MYO9B NCOA1 NDUFAF6 NEIL2 NELFCD NGF NOC3L NPPA-AS1 NPR3 NRBF2 NSUN6 NT5C2 OPRL1 OSGIN2 PDE1A PDLIM4 PDXK PHIP PIGV PKP4 PLCB1 PMS2P5 PRDM8 PRELID1P1 PRKD3 PTPN12 PVRIG RGS19 RNF34 RP11-436D10.3 RP11-463M16.4 RP11-538P18.2 RP11-588K22.2 RP11-613D13.5 RP11-810M2.2 RP1-197B17.3 RP4-635E18.7 RP4-758J18.10 RP5-1115A15.1 RPP25 RUVBL1 RYK SENP1 SENP3 SH2B3 SIK2 SIPA1 SLC2A4 SLC35F6 SLC4A7 SRR STAG3L1 SWAP70 TBC1D12 TBC1D19 TDRD1 TEAD2 TEX15 TIRAP TMEM133 TMEM170A TNKS1BP1 TNNT3 TPD52L2 TSPY26P UBE2E3 UBL3 UFL1 ULK3 USP37 VANGL1 WDR66 WNT2B WNT3 YEATS4 ZBTB46 ZNF318
Gastro-oesophageal reflux (gord) / gastric reflux (Self-reported) 1.22 1 0 0.0 0.00 1.0e+00 KDM2B
Illnesses of father: Heart disease 1.98 2 1 3.0 0.00 1.0e+00 FES RGS19
Smoking status: Previous 1.22 2 0 0.0 0.00 1.0e+00 MAP2K5 SH2B3
Forced expiratory volume in 1-second (FEV1), predicted 1.46 3 2 6.1 0.00 1.0e+00 DCAF16 MGRN1 PDLIM4
Whole body fat-free mass 1.91 26 15 45.5 0.01 9.7e-01 CCDC112 CENPW DCAF16 DOC2A KAT8 KCNK3 KIAA1199 KLF16 MAP2K5 MYO9B NEIL2 NPR3 NT5C2 PDE1A PDLIM4 PRELID1P1 RP11-436D10.3 SENP3 SH2B3 SLC35F6 SLC4A7 STAG3L1 TBC1D12 TEAD2 ULK3 WDR66
Leg fat-free mass (right) 1.90 28 15 45.5 0.04 8.5e-01 ABCF3 CENPW DCAF16 DOC2A FES KAT8 KCNK3 KIAA1199 KLF16 MAP2K5 MSRA MYO9B NEIL2 NPR3 NT5C2 PDE1A PDLIM4 PRELID1P1 RP11-436D10.3 SH2B3 SLC35F6 SRR STAG3L1 TBC1D12 TDRD1 TMEM133 ULK3 WDR66
Arm fat percentage (left) 2.16 25 15 45.5 0.71 6.7e-05 AARS CHP1 COX5A CTB-31O20.6 DCAF16 DOC2A FBF1 KAT8 KCNK3 KDM2B KLF16 MAP2K5 MSRA NT5C2 PMS2P5 RNF34 RP11-613D13.5 RP11-810M2.2 RP5-1115A15.1 RPP25 SENP3 SIPA1 SRR STAG3L1 TEX15
Average weekly red wine intake 1.32 2 0 0.0 0.00 1.0e+00 MPI NRBF2
Mood swings 1.15 3 0 0.0 0.00 1.0e+00 ACP2 OSGIN2 WNT3
Loneliness, isolation 1.25 2 0 0.0 0.00 1.0e+00 RP5-1115A15.1 SH2B3
Long-standing illness, disability or infirmity 1.66 3 0 0.0 0.00 1.0e+00 CHP1 DBR1 PMS2P5
Ever had bowel cancer screening 1.04 1 0 0.0 0.00 1.0e+00 SIK2
Diabetes diagnosed by doctor 2.33 5 3 9.1 0.96 1.0e-02 ACE DBR1 KCNJ11 PMS2P5 ZBTB46
Mouth/teeth dental problems: Mouth ulcers 1.19 2 0 0.0 0.00 1.0e+00 OSGIN2 WNT3
Medication for cholesterol 6.31 26 7 21.2 -0.97 4.9e-17 ACE AGT ATG7 C4orf22 C6orf174 CDK10 CENPW CISD2 CWF19L2 FES JARID2 KAT8 KIAA1199 LIME1 MGRN1 PIGV PLCB1 PRELID1P1 PRKD3 SENP1 SH2B3 TMEM133 TNKS1BP1 TNNT3 WNT2B ZBTB46
Back pain experienced in last month 1.63 1 0 0.0 0.00 1.0e+00 WDR66
Mineral and other dietary supplements 1.18 1 0 0.0 0.00 1.0e+00 NRBF2
Breast cancer (self-reported) 1.24 1 1 3.0 0.00 1.0e+00 SLC4A7
Asthma (self-reported) 1.63 5 3 9.1 0.25 6.8e-01 FBF1 PDLIM4 RP5-1115A15.1 RUVBL1 SIK2
Osteoarthritis (self-reported) 1.58 2 0 0.0 0.00 1.0e+00 COX5A RPP25
Medication: Aspirin 3.56 5 1 3.0 0.96 8.2e-03 FES OPRL1 RGS19 RP11-463M16.4 SIK2
Medication: Gliclazide 1.64 2 0 0.0 0.00 1.0e+00 DBR1 KCNJ11
Illnesses of father: None of the above (group 1) 2.29 2 1 3.0 0.00 1.0e+00 FES SH2B3
Forced expiratory volume in 1-second (FEV1), predicted percentage 1.72 6 3 9.1 -0.27 6.1e-01 KAT8 NRBF2 OPRL1 RP11-538P18.2 TMEM170A WNT3
Whole body water mass 1.92 29 15 45.5 0.03 8.8e-01 CCDC112 CENPW DCAF16 DOC2A KAT8 KCNK3 KIAA1199 KLF16 LIME1 MAP2K5 MSRA MYO9B NEIL2 NPR3 NT5C2 PDE1A PDLIM4 PRELID1P1 RP11-436D10.3 SENP3 SH2B3 SLC35F6 SLC4A7 STAG3L1 TBC1D12 TEAD2 TMEM133 ULK3 WDR66
Leg predicted mass (right) 1.89 28 15 45.5 0.04 8.5e-01 ABCF3 CENPW DCAF16 DOC2A FES KAT8 KCNK3 KIAA1199 KLF16 MAP2K5 MSRA MYO9B NEIL2 NPR3 NT5C2 PDE1A PDLIM4 PRELID1P1 RP11-436D10.3 SH2B3 SLC35F6 SRR STAG3L1 TBC1D12 TDRD1 TMEM133 ULK3 WDR66
Arm fat mass (left) 2.16 23 12 36.4 0.72 1.1e-04 AARS COX5A CTB-31O20.6 DOC2A KAT8 KCNK3 KDM2B KIAA1199 KLF16 MAP2K5 MSRA NT5C2 PMS2P5 RP11-613D13.5 RP11-810M2.2 RP5-1115A15.1 RPP25 SIPA1 SRR STAG3L1 TDRD1 TEAD2 TEX15
Number of self-reported non-cancer illnesses 4.19 11 3 9.1 0.99 7.6e-11 CISD2 KDM2B LSMD1 MYO9B OPRL1 PDLIM4 PMS2P5 RGS19 RUVBL1 SH2B3 ZNF318
Miserableness 1.11 3 0 0.0 0.00 1.0e+00 ACP2 RP5-1115A15.1 WNT3
Guilty feelings 1.02 1 0 0.0 0.00 1.0e+00 NEIL2
Mother's age at death 1.76 1 0 0.0 0.00 1.0e+00 CLCN6
Financial situation satisfaction 1.26 1 0 0.0 0.00 1.0e+00 ULK3
Eye problems/disorders: Glaucoma 1.29 1 0 0.0 0.00 1.0e+00 TEX15
Medication: Blood pressure 10.04 78 34 103.0 0.98 2.1e-60 ACE ACP2 AGT AGTRAP AKR1B1 AQP5 ARID3B ATG7 ATP2B1 C1GALT1 C4orf22 C6orf174 CDK10 CENPW CERS5 CHP1 CISD2 CLCN6 COX5A CSK CTB-31O20.6 CWF19L2 CYP11A1 DBR1 FCF1P2 FES GTF2B HRCT1 KAT8 KB-1107E3.1 KCNK3 KDM2B KIAA1199 LFNG LIME1 LSMD1 MGRN1 MPI MSRA MYO9B NCOA1 NEIL2 NRBF2 NSUN6 NT5C2 PDLIM4 PDXK PIGV PLCB1 PRELID1P1 PRKD3 PTPN12 RGS19 RNF34 RP11-436D10.3 RP11-588K22.2 RP11-810M2.2 RP4-635E18.7 RPP25 SENP3 SH2B3 SIK2 SIPA1 SLC35F6 SLC4A7 TBC1D19 TDRD1 TEX15 TMEM133 TNKS1BP1 TNNT3 TPD52L2 UBL3 ULK3 WNT2B WNT3 ZBTB46 ZNF318
High cholesterol (Self-reported) 3.16 8 5 15.2 0.90 4.4e-04 AARS CWF19L2 DCAF16 FBF1 OPRL1 PIGV RGS19 TMEM133
Medication: Bendroflumethiazide 7.01 32 7 21.2 0.97 9.5e-21 ABCF3 ACP2 ATP2B1 C6orf174 CCDC112 CD164L2 CDK10 CSK DOC2A FES JPH2 KAT8 KIAA1199 MGRN1 MYO9B NEIL2 NRBF2 PDLIM4 PIGV PLCB1 PRELID1P1 RP11-436D10.3 RP11-463M16.4 SENP3 SH2B3 SLC35F6 SLC4A7 TEX15 TMEM133 TNNT3 USP37 WNT2B
Medication: Paracetamol 1.60 1 0 0.0 0.00 1.0e+00 UFL1
Medication: Lisinopril 3.98 5 0 0.0 0.97 6.0e-03 ACP2 CSK FCF1P2 NRBF2 TMEM133
Illnesses of father: High blood pressure 3.59 6 1 3.0 0.98 7.1e-04 ACE ACP2 C4orf22 FES NCOA1 PLCB1
Ever smoked 1.32 3 0 0.0 0.00 1.0e+00 MAP2K5 SH2B3 SRR
Basal metabolic rate 1.92 25 16 48.5 0.15 4.6e-01 CCDC112 CENPW DCAF16 DOC2A KAT8 KCNK3 KIAA1199 KLF16 MAP2K5 MSRA NEIL2 NPR3 NT5C2 PDE1A PDLIM4 PRELID1P1 RP11-436D10.3 RP11-613D13.5 SH2B3 SLC35F6 STAG3L1 TDRD1 TEAD2 ULK3 WDR66
Leg fat percentage (left) 2.28 27 10 30.3 0.77 3.0e-06 AARS CHP1 COX5A CTB-31O20.6 DCAF16 DOC2A GTF2B KAT8 KCNK3 KDM2B MAP2K5 MSRA NOC3L NRBF2 PKP4 PMS2P5 RP11-613D13.5 RP11-810M2.2 RP5-1115A15.1 RPP25 SIPA1 SLC2A4 STAG3L1 TBC1D12 TEX15 TSPY26P WNT2B
Arm fat-free mass (left) 1.93 27 13 39.4 0.14 4.8e-01 CENPW DCAF16 DOC2A KAT8 KCNK3 KIAA1199 KLF16 LIME1 MAP2K5 MSRA NEIL2 NPR3 NT5C2 PDE1A PDLIM4 PRELID1P1 RP11-613D13.5 RP11-810M2.2 SENP3 SH2B3 SLC35F6 SLC4A7 STAG3L1 TEAD2 TSPY26P ULK3 WDR66
Average weekly beer plus cider intake 1.42 3 1 3.0 0.00 1.0e+00 AQP5 CCDC112 NRBF2
Irritability 1.10 2 2 6.1 0.00 1.0e+00 MSRA NEIL2
Risk taking 1.14 1 0 0.0 0.00 1.0e+00 KCNK3
Diastolic blood pressure, automated reading 7.75 75 45 136.4 0.97 2.0e-51 AC006111.1 ACP2 AGT AGTRAP AQP5 ATP2B1 C1GALT1 C20orf160 C4orf22 C6orf174 CCDC112 CENPW CEP41 CERS5 CHP1 CLCN6 COX5A CSK CTB-31O20.6 CYP11A1 DBR1 DCAF16 DRAXIN ENPEP FCF1P2 FES GLTP HRCT1 KAT8 KIAA1199 KIF2A LFNG LIME1 LSMD1 MAP2K5 MED21 MFN2 MPI MSRA MYO9B NCOA1 NDUFAF6 NEIL2 NELFCD NOC3L NPPA-AS1 NRBF2 NSUN6 NT5C2 PDE1A PDLIM4 PHIP PIGV PMS2P5 PRELID1P1 PVRIG RP11-436D10.3 RP11-463M16.4 RP11-538P18.2 RP5-1115A15.1 RPP25 RYK SENP3 SH2B3 SIPA1 SLC2A4 SRR STAG3L1 SWAP70 TBC1D12 TMEM133 TNNT3 TSPY26P ULK3 WNT2B
Vascular/heart problems diagnosed by doctor 13.11 147 107 324.2 -1.00 9.4e-177 AARS ABCF3 AC006111.1 ACE ACP2 AGT AGTRAP AKR1B1 ALOX12 AQP5 ARID3B ATG7 ATP2B1 C1GALT1 C1orf50 C20orf160 C3orf63 C4orf22 C6orf174 CAND1 CCDC112 CD164L2 CDK10 CENPW CEP41 CERS5 CHP1 CISD2 CLCN6 COX5A CSK CTB-31O20.6 CWF19L2 CYP11A1 DBR1 DCAF16 DOC2A DRAXIN ENPEP EXOC4 FBF1 FCF1P2 FES FLJ13197 GLTP GOPC GTF2B HOXB2 HRCT1 JARID2 JPH2 KAT2B KAT8 KB-1107E3.1 KCNK3 KDM2B KIAA1199 KIF2A KLF16 KREMEN1 LDB3 LFNG LIME1 LSMD1 MAP2K5 MED21 MFN2 MGRN1 MPI MSRA MYO9B NCOA1 NDUFAF6 NEIL2 NELFCD NGF NOC3L NPPA-AS1 NPR3 NRBF2 NSUN6 NT5C2 OPRL1 OSGIN2 PDE1A PDLIM4 PDXK PHIP PIGV PKP4 PLCB1 PMS2P5 PRDM8 PRELID1P1 PRKD3 PTPN12 PVRIG RGS19 RNF34 RP11-436D10.3 RP11-463M16.4 RP11-538P18.2 RP11-588K22.2 RP11-613D13.5 RP11-810M2.2 RP1-197B17.3 RP4-635E18.7 RP4-758J18.10 RP5-1115A15.1 RPP25 RUVBL1 RYK SENP1 SENP3 SH2B3 SIK2 SIPA1 SLC2A4 SLC35F6 SLC4A7 SRR STAG3L1 SWAP70 TBC1D12 TBC1D19 TDRD1 TEAD2 TEX15 TIRAP TMEM133 TMEM170A TNKS1BP1 TNNT3 TPD52L2 TSPY26P UBE2E3 UBL3 UFL1 ULK3 USP37 VANGL1 WDR66 WNT2B WNT3 YEATS4 ZBTB46 ZNF318
Cholesterol lowering medication 2.75 7 3 9.1 0.99 3.9e-08 DCAF16 KAT8 MGRN1 OPRL1 PIGV RGS19 RNF34
Pain experienced in last month 1.41 2 0 0.0 0.00 1.0e+00 KAT8 UFL1
Basal cell carcinoma (self-reported) 1.19 1 1 3.0 0.00 1.0e+00 CDK10
Heart attack/myocardial infarction (self-reported) 2.10 2 1 3.0 0.00 1.0e+00 FES SH2B3
Heart disease (siblings) 1.72 2 0 0.0 0.00 1.0e+00 FES PVRIG
Pack years of smoking 1.20 1 0 0.0 0.00 1.0e+00 PMS2P5
Impedance of whole body 2.26 43 25 75.8 -0.22 1.6e-01 AARS ABCF3 ATG7 CENPW CEP41 CERS5 CISD2 CTB-31O20.6 CYP11A1 DOC2A EXOC4 JPH2 KAT8 KCNJ11 KCNK3 KIAA1199 KLF16 LIME1 MAP2K5 MSRA MYO9B NEIL2 NOC3L NRBF2 NT5C2 OPRL1 PDE1A PMS2P5 PRKD3 RGS19 RP11-463M16.4 RP4-758J18.10 RYK SENP1 SENP3 SLC4A7 SRR STAG3L1 SWAP70 TBC1D12 ULK3 USP37 WNT2B
Leg fat mass (left) 2.21 24 13 39.4 0.69 2.0e-04 AARS COX5A CTB-31O20.6 DOC2A KAT8 KB-1107E3.1 KCNK3 KDM2B KIAA1199 KLF16 MAP2K5 MSRA PMS2P5 RP11-613D13.5 RP11-810M2.2 RP5-1115A15.1 RPP25 STAG3L1 TDRD1 TEAD2 TEX15 TSPY26P ULK3 WNT2B
Arm predicted mass (left) 1.93 27 12 36.4 0.14 4.7e-01 CENPW DCAF16 DOC2A KAT8 KCNK3 KIAA1199 KLF16 LIME1 MAP2K5 MSRA NCOA1 NEIL2 NPR3 NT5C2 PDE1A PDLIM4 PRELID1P1 RP11-613D13.5 RP11-810M2.2 SENP3 SH2B3 SLC35F6 SLC4A7 STAG3L1 TEAD2 ULK3 WDR66

Associations by panel

study tissue # hits % hits/tests avg chisq
GTEx Adipose Subcutaneous 34 0.974 2.97
GTEx Adipose Visceral Omentum 17 0.835 2.98
GTEx Adrenal Gland 13 0.892 2.91
GTEx Artery Aorta 42 1.411 3.12
GTEx Artery Coronary 8 0.676 2.92
GTEx Artery Tibial 41 1.090 3.03
GTEx Brain Caudate basal ganglia 7 0.761 2.87
GTEx Brain Cerebellar Hemisphere 15 1.007 2.90
GTEx Brain Cerebellum 15 0.757 3.04
GTEx Brain Cortex 8 0.773 3.08
GTEx Brain Frontal Cortex BA9 8 0.866 3.03
GTEx Brain Hippocampus 2 0.382 2.85
GTEx Brain Hypothalamus 2 0.339 2.64
GTEx Brain Nucleus accumbens basal ganglia 5 0.578 2.93
GTEx Brain Putamen basal ganglia 4 0.641 2.71
GTEx Breast Mammary Tissue 16 0.811 2.89
GTEx Breast Mammary Tissue (Male) 16 1.341 2.87
GTEx Breast Mammary Tissue (Female) 15 0.912 2.88
GTEx Cells EBV-transformed lymphocytes 8 0.562 2.86
GTEx Cells Transformed fibroblasts 37 0.881 2.86
GTEx Colon Sigmoid 11 0.752 2.94
GTEx Colon Transverse 16 0.775 2.92
GTEx Esophagus Gastroesophageal Junction 16 1.107 3.02
GTEx Esophagus Mucosa 34 1.024 2.90
GTEx Esophagus Muscularis 36 1.114 2.92
GTEx Heart Atrial Appendage 14 0.887 2.85
GTEx Heart Left Ventricle 18 1.176 2.96
GTEx Liver 5 0.697 2.67
GTEx Lung 23 0.801 2.97
GTEx Muscle Skeletal 19 0.657 2.94
GTEx Nerve Tibial 33 0.764 2.81
GTEx Ovary 11 1.211 3.27
GTEx Pancreas 15 0.919 2.95
GTEx Pituitary 9 0.807 2.89
GTEx Prostate 12 1.437 3.19
GTEx Skin Not Sun Exposed Suprapubic 26 1.057 3.01
GTEx Skin Sun Exposed Lower leg 41 1.126 2.94
GTEx Small Intestine Terminal Ileum 2 0.434 2.96
GTEx Spleen 13 0.921 2.85
GTEx Stomach 19 1.307 3.13
GTEx Testis 31 0.983 2.93
GTEx Thyroid 38 0.950 2.89
GTEx Uterus 6 1.058 2.84
GTEx Vagina 6 0.945 2.94
GTEx Whole Blood 14 0.702 2.79
METSIM Adipose 24 0.521 2.57
NTR Blood 21 0.874 2.76
ROSMAP Brain Pre-frontal Cortex 51 1.161 2.99
YFS Blood 26 0.563 2.58
CommonMind Brain Pre-frontal Cortex 46 0.856 2.71
TCGA Breast Tumor 10 1.304 3.05
TCGA Breast Normal 24 0.570 2.53
TCGA Ovarian Tumor 12 0.411 2.42
TCGA Prostate Tumor 26 0.752 2.67